Everolimus in postmenopausal hormone-receptor-positive Advanced Breast Cancer The Breast Cancer Trials of Oral Everolimus-2 (BOLERO-2)

被引：0
|
作者：
Hadoux, J.
Delaloge, S.
机构：
来源：
ONCOLOGIE | 2012年 / 14卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：349 / 350
页数：2
相关论文
共 50 条
  • [1] Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
    Baselga, Jose
    Campone, Mario
    Piccart, Martine
    Burris, Howard A., III
    Rugo, Hope S.
    Sahmoud, Tarek
    Noguchi, Shinzaburo
    Gnant, Michael
    Pritchard, Kathleen I.
    Lebrun, Fabienne
    Beck, J. Thaddeus
    Ito, Yoshinori
    Yardley, Denise
    Deleu, Ines
    Perez, Alejandra
    Bachelot, Thomas
    Vittori, Luc
    Xu, Zhiying
    Mukhopadhyay, Pabak
    Lebwohl, David
    Hortobagyi, Gabriel N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06): : 520 - 529
  • [2] The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer
    Beaver, Julia A.
    Park, Ben H.
    [J]. FUTURE ONCOLOGY, 2012, 8 (06) : 651 - 657
  • [3] EVEROLIMUS-ASSOCIATED ADVERSE EVENTS IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER UPDATED RESULTS FROM BOLERO-2
    Campbell-Baird, Cynthia
    [J]. ONCOLOGY NURSING FORUM, 2013, 40 (06) : E428 - E428
  • [4] Everolimus beim metastasierten hormonrezeptorpositiven MammakarzinomEverolimus in postmenopausal hormone-receptor-positive advanced breast cancer
    C. Richter-Ehrenstein
    [J]. Der Onkologe, 2012, 18 (5): : 435 - 437
  • [5] Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2
    Noguchi, Shinzaburo
    Masuda, Norikazu
    Iwata, Hiroji
    Mukai, Hirofumi
    Horiguchi, Jun
    Puttawibul, Puttisak
    Srimuninnimit, Vichien
    Tokuda, Yutaka
    Kuroi, Katsumasa
    Iwase, Hirotaka
    Inaji, Hideo
    Ohsumi, Shozo
    Noh, Woo-Chul
    Nakayama, Takahiro
    Ohno, Shinji
    Rai, Yoshiaki
    Park, Byeong-Woo
    Panneerselvam, Ashok
    El-Hashimy, Mona
    Taran, Tetiana
    Sahmoud, Tarek
    Ito, Yoshinori
    [J]. BREAST CANCER, 2014, 21 (06) : 703 - 714
  • [6] Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2
    Shinzaburo Noguchi
    Norikazu Masuda
    Hiroji Iwata
    Hirofumi Mukai
    Jun Horiguchi
    Puttisak Puttawibul
    Vichien Srimuninnimit
    Yutaka Tokuda
    Katsumasa Kuroi
    Hirotaka Iwase
    Hideo Inaji
    Shozo Ohsumi
    Woo-Chul Noh
    Takahiro Nakayama
    Shinji Ohno
    Yoshiaki Rai
    Byeong-Woo Park
    Ashok Panneerselvam
    Mona El-Hashimy
    Tetiana Taran
    Tarek Sahmoud
    Yoshinori Ito
    [J]. Breast Cancer, 2014, 21 : 703 - 714
  • [7] Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
    Piccart, M.
    Hortobagyi, G. N.
    Campone, M.
    Pritchard, K. I.
    Lebrun, F.
    Ito, Y.
    Noguchi, S.
    Perez, A.
    Rugo, H. S.
    Deleu, I.
    Burris, H. A., III
    Provencher, L.
    Neven, P.
    Gnant, M.
    Shtivelband, M.
    Wu, C.
    Fan, J.
    Feng, W.
    Taran, T.
    Baselga, J.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (12) : 2357 - 2362
  • [8] BOLERO-2: EVEROLIMUS IN COMBINATION WITH EXEMESTANE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST CANCER REFRACTORY TO LETROZOLE OR ANASTROZOLE
    Campone, Mario
    Piccart, Martine
    Pritchard, Kathleen I.
    Xu, Cindy
    Gnant, Michael
    Neven, Patrick
    Pistilli, Barbara
    Shtivelband, Mikhail
    Provencher, Louise
    Masuda, Norikazu
    El-Hashimy, Mona
    Vittori, Luc
    Sahmoud, Tarek
    Baselga, Jose
    Hortobagyi, Gabriel N.
    [J]. BREAST, 2011, 20 : S30 - S30
  • [9] Everolimus for Postmenopausal Women with Advanced Breast Cancer: Updated Results of the BOLERO-2 Phase Ill Trial.
    Hortobagyi, G. N.
    Piccart, M.
    Rugo, H.
    Burris, H.
    Campone, M.
    Noguchi, S.
    Gnant, M.
    Pritchard, K. I.
    Vittori, L.
    Mukhopadhyay, P.
    Sahmoud, T.
    Lebwohl, D.
    Baselga, J.
    [J]. CANCER RESEARCH, 2011, 71
  • [10] Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.
    Piccart-Gebhart, Martine J.
    Noguchi, Shinzaburo
    Pritchard, Kathleen I.
    Burris, Howard A.
    Rugo, Hope S.
    Gnant, Michael
    Hortobagyi, Gabriel N.
    Melichar, Bohuslav
    Petrakova, Katarina
    Arena, Francis P.
    Xu, Cindy
    Cahana, Ayelet
    Taran, Tanya
    Sahmoud, Tarek
    Lebwohl, David Edward
    Campone, Mario
    Baselga, Jose
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345